Rebecca Kesselring

6PUBLICATIONS
80CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 22, 2026
Novel Syngeneic Cell Lines for Studying High-Risk BRAFV600E-Driven Colorectal Cancer In Vivo.

Jasmin Traichel, Ariane Metzger, Maria Walz

|Jun 25, 2025
Metabolic surgery reduces CRC disease progression through circulating bile acid diversion.

Claudia Lässle, Bernhard Mauerer, Lisa Marx

|Nov 27, 2024
Long-Term Outcome After Resection of Hepatic and Pulmonary Metastases in Multivisceral Colorectal Cancer.

Christopher Berlin, Geoffroy Andrieux, Magdalena Menzel

|Jul 25, 2023
Colorectal Cancer Organoid-Stroma Biobank Allows Subtype-Specific Assessment of Individualized Therapy Responses.

Henner F Farin, Mohammed H Mosa, Benardina Ndreshkjana

|Jan 17, 2023
Tyrosine kinase inhibitors can activate the NLRP3 inflammasome in myeloid cells through lysosomal damage and cell lysis.

Emilia Neuwirt, Giovanni Magnani, Tamara Ćiković

|Nov 05, 2021
KMT9 Controls Stemness and Growth of Colorectal Cancer.

Christopher Berlin, Félicie Cottard, Dominica Willmann

Pageof 1